^{D NURSE}

^{MOBILE GLUCOSE METER}

^{specification}

^{Blood sample:fresh capillary whole blood,}

^{venous whole blood}

^{Blood volume:0.6ul}

^{Test range:20-600mg/dL(1.1-33.3mmol/L)}

^{Test time:10s}

^{Battery lifetime:4000 tests}

^{Operating temperature:10℃-35℃}

^{Volume:40X30X8mm}

Sinocare is a high-tech enterprise dedicated to the development, production and sales of the rapid detection of chronic diseases in the use of bio sensing technology. Since its inception in 2002, has been adhering to the business purpose “Honor Commitment Dedicate to Healthcare", focus on promoting the development of diabetes health.

Sinocare is a high-tech enterprise dedicated to the development, production and sales of the rapid detection of chronic diseases in the use of bio sensing technology. Since its inception in 2002, has been adhering to the business purpose “Honor Commitment Dedicate to Healthcare", focus on promoting the development of diabetes health.

Sinocare as a national high-tech industrialization demonstration project, has won National Innovation Fund support, and took the lead through the ISO 13485 Quality Management System certification and the CE certification of EU. The SANNUO series blood glucose meter and a test strips, with the characteristics of the "accuracy, simple and economic", recognized by the vast number of consumers, the "Sinocare" trademark was identified as "China well known trademark by State Administration of industry and Commerce of. The products are not only popular in China, but also in the international market. In March 19, 2012, the company listed on the Shenzhen stock exchange gem, as the first Bio sensor stock in China. In 2015， the blood glucose meter in the domestic retail market share reached 51%, becoming the industry leader in blood glucose monitoring products, the same year was elected to the Forbes Asian small and medium companies top 200 list. In 2014 September，Sinocare acquired Beijing Jianheng Diabetes Hospital，to step into health service area. In January of 2016, Sinocare acquired Nipro diagnostic Inc. (now renamed as Trividia Health Inc.), the world's sixth BGM enterprise, and reached the international leading BGM corporation, In July of 2016, completed acquisition of PTS Diagnostics, expand the POCT testing business, to provide a more comprehensive solution for chronic disease prevention.